Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present BioXcel Therapeutics, Inc. (NASDAQ: BTAI).

Full DD Report for BTAI

You must become a subscriber to view this report.


Recent News from (NASDAQ: BTAI)

BioXcel Therapeutics Announces Data Presentation at ASCO 2018 Annual Meeting
BRANFORD, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, to...
Source: GlobeNewswire
Date: May, 17 2018 08:00
BioXcel Therapeutics misses by $0.10
BioXcel Therapeutics (NASDAQ: BTAI ): Q1 EPS of -$0.37 misses by $0.10 . More news on: BioXcel Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 14 2018 16:33
BioXcel Therapeutics Reports First Quarter 2018 Financial Results and Provides Business Update
BRANFORD, Conn., May 14, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, to...
Source: GlobeNewswire
Date: May, 14 2018 16:01
BioXcel Therapeutics Announces Acceptance of Abstract at ASCO 2018 Annual Meeting
BRANFORD, Conn., April 26, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, ...
Source: GlobeNewswire
Date: April, 26 2018 08:30
Midday Gainers / Losers (04/24/2018)
Gainers: CHEK +69% . ATOS +40% . LEDS +22% . CLDC +20% . SANM +18% . HSII +17% . HLX +16% . SC +16% . MARA +12% . LYL +11% . More news on: Check-Cap Ltd., Atossa Genetics, Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 24 2018 12:40
BioXcel Therapeutics to Ring the NASDAQ Stock Market Opening Bell on April 20, 2018
BRANFORD, Conn., April 19, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, ...
Source: GlobeNewswire
Date: April, 19 2018 08:30
Premarket analyst action - healthcare
BioXcel Therapeutics (Pending: BTAI ) initiated with Overweight rating and $15 (46% upside) price target at Barclays. Initiated with Buy rating and $18 price target at UBS. Initiated with Outperform rating and $23 price target at BMO Capital Markets. Initiated with Buy rating and $21 price t...
Source: SeekingAlpha
Date: April, 02 2018 08:39
Strap In For Spotify, Tesla And FANG+ Action
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. Tech darlings look to recover their swagger after a wave of negative news over the ...
Source: SeekingAlpha
Date: March, 31 2018 08:01
BioXcel Therapeutics Announces Closing of Initial Public Offering
BRANFORD, Conn., March 12, 2018 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, ...
Source: GlobeNewswire
Date: March, 12 2018 16:01
U.S. IPO Weekly Recap: Another Billion-Dollar IPO Filing As Activity Prepares To Pick Up
The lull is over. The annual February pause in IPO activity lasted longer than normal, but 2018's record-breaking start now looks ready to resume. This week IPOs began launching and another billion-dollar IPO joined the pipeline . One IPO priced this week, the first in almost a month. AI-ba...
Source: SeekingAlpha
Date: March, 10 2018 12:08

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-179.8910.5410.698.9217,841

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1515,37330,63750.1779Short
2018-08-142,6729,22228.9742Cover
2018-08-136,42213,25848.4387Short
2018-08-103,58510,41234.4314Cover
2018-08-092,59613,34519.4530Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BTAI.


About BioXcel Therapeutics, Inc. (NASDAQ: BTAI)

Logo for BioXcel Therapeutics, Inc. (NASDAQ: BTAI)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: BTAI)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 17 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 14 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 14 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 26 2018
      Statement of beneficial ownership of common stock by certain persons
      Filing Type: SC 13GFiling Source: edgar
      Filing Date: April, 10 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 13 2018
      Prospectus filed under Rule 424(b)(4)
      Filing Type: 424B4Filing Source: edgar
      Filing Date: March, 09 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: March, 08 2018
      Notice from the SEC of registration effectiveness
      Filing Type: EFFECTFiling Source: edgar
      Filing Date: March, 07 2018
      Amendment to general form for registration of securities under the Securities Act of 1933
      Filing Type: S-1/AFiling Source: edgar
      Filing Date: March, 05 2018

       

       


      Daily Technical Chart for (NASDAQ: BTAI)

      Daily Technical Chart for (NASDAQ: BTAI)


      Stay tuned for daily updates and more on (NASDAQ: BTAI)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: BTAI)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BTAI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BTAI and does not buy, sell, or trade any shares of BTAI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/